Drug: Oxycodone CR: chronic pain clinical trials
Registry records that list "Drug: Oxycodone CR" as an intervention. Being studied does not mean an intervention works or is approved.
1
Trials with Canadian sites
0
Recruiting in Canada
4
Registry records in total
Trials in Canada
1 trial, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Provinces | ||||
|---|---|---|---|---|---|
| A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain NCT00361504 | Completed | Phase 3 | Alberta, British Columbia, Nova Scotia, Ontario and 2 more | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-11 |
Trials worldwide (outside Canada)
3 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain NCT01709214 | Completed | Phase 2 | United States | Tris Pharma, Inc. | 2012-12-04 |
| A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain NCT01165281 | Completed | Phase 3 | Japan, South Korea | Janssen Research & Development, LLC | 2010-08 |
| A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain NCT00449176 | Completed | Phase 3 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-02 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.